13 Spam-Free Article(s) Found
Article Searches
Biotech Stocks, ETFs to Gain on COVID-19 Vaccine & Drug Progress http://www.zacks.com/stock/news/859545/biotech-stocks-etfs-to-gain-on-covid-19-vaccine-drug-progress?cid=CS-ZC-FT-etf_news_and_commentary-859545 Apr 07, 2020 - The race to introduce a vaccine and drug for COVID-19 is creating near-term opportunities, making the biotech sector a lucrative space for investments.
Incyte to Evaluate Lead Drug Jakafi for COVID-19 Infection http://www.zacks.com/stock/news/852806/incyte-to-evaluate-lead-drug-jakafi-for-covid-19-infection?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-852806 Apr 03, 2020 - Incyte (INCY) plans to work with the FDA for evaluating Jakafi in patients with COVID-19-associated cytokine storm.
Incyte to Test Its Cancer Drug Jakafi as a Treatment for COVID-19 https://www.fool.com/investing/2020/04/02/incyte-to-test-its-cancer-drug-jakafi-as-a-treatme.aspx?source=iedfolrf0000001 Apr 02, 2020 - Both diseases involve an overactive immune system.

Pages: 12

<Page 2